LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

Home・Aandelen Lijst・Avita Therapeutics Inc

Avita Therapeutics Inc

Gesloten

4.03 -4.05

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.85

Max

4.18

Belangrijke statistieken
By Trading Economics
Inkomsten	1.6M -12M
Verkoop	554K 18M
EPS	-0.536
Winstmarge	-65.968
Werknemers	226
EBITDA	1.6M -9.7M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+51.07% upside

Dividenden
By Dow Jones
Volgende Winsten	7 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	18M 142M
Vorige openingsprijs	8.08
Vorige sluitingsprijs	4.03

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

8.83 / 9.77 Steun & Weerstand

Avita Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 mrt 2026, 18:34 UTC

Winsten

Canada to Allow Smaller Companies to Ax Quarterly Earnings Reports in Pilot

19 mrt 2026, 17:43 UTC

Belangrijke Marktbewegers

Ecolab Dips on Report of Deal for CoolIT Systems With KKR

19 mrt 2026, 23:47 UTC

Winsten

COSCO SHIPPING Holdings: Geopolitical Tensions Will Continue Driving Regional Fragmentation >1919.HK

19 mrt 2026, 23:47 UTC

Winsten

COSCO SHIPPING Holdings: Container Shipping Market Saw Fluctuating, Declining Freight Rates >1919.HK

19 mrt 2026, 23:47 UTC

Winsten

COSCO SHIPPING Holdings 2025 Rev CNY219.50B Vs. CNY233.86B >1919.HK

19 mrt 2026, 23:47 UTC

Winsten

COSCO SHIPPING Holdings 2025 Net CNY30.86B Vs. Net CNY49.17B >1919.HK

19 mrt 2026, 23:39 UTC

Winsten

Li Ning 2025 Net CNY2.94B Vs. Net CNY3.01B >2331.HK

19 mrt 2026, 23:39 UTC

Winsten

Li Ning: Will Continue Targeting Consumer Needs, Strengthening User Engagement >2331.HK

19 mrt 2026, 23:39 UTC

Winsten

Li Ning: Outdoor Category Continued Growing >2331.HK

19 mrt 2026, 23:38 UTC

Winsten

Li Ning 2025 Rev CNY29.60B Vs. CNY28.68B >2331.HK

19 mrt 2026, 23:33 UTC

Marktinformatie

Gold Edges Lower on Inflation Concerns, Dimmed Fed Rate-Cut Hopes -- Market Talk

19 mrt 2026, 22:42 UTC

Acquisities, Fusies, Overnames

Unilever in Talks to Separate Food Business and Combine It With McCormick -- WSJ

19 mrt 2026, 22:42 UTC

Acquisities, Fusies, Overnames

McCormick Has a Market Value of Around $14.8B -- WSJ

19 mrt 2026, 22:42 UTC

Acquisities, Fusies, Overnames

Unilever in Talks to Combine Food Business With McCormick, Sources Say -- WSJ

19 mrt 2026, 22:42 UTC

Acquisities, Fusies, Overnames

All-Stock Unilever-McCormick Deal Could Come Together Within Weeks, Sources Say -- WSJ

19 mrt 2026, 22:23 UTC

Marktinformatie

FedEx Says It Can Raise Prices to Offset Higher Fuel Costs -- Market Talk

19 mrt 2026, 22:09 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Australian Transport Stocks to Trade at Discount On Fuel Risks -- Market Talk

19 mrt 2026, 22:06 UTC

Marktinformatie

Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

19 mrt 2026, 22:04 UTC

Winsten

Acquisities, Fusies, Overnames

FedEx CFO: MD-11 Grounding Led to $120M Headwind to Adjusted Operating Income in 3Q

19 mrt 2026, 22:03 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Energy Roundup: Market Talk

19 mrt 2026, 22:03 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Fuel Prices, Scarcity Could Leave Mark on Australia's Gold Miners -- Market Talk

19 mrt 2026, 21:51 UTC

Winsten

Acquisities, Fusies, Overnames

FedEx CEO: InPost Deal Expected to Be Accretive to Earnings in Year One After Close

19 mrt 2026, 20:57 UTC

Belangrijke Nieuwsgebeurtenissen

Middle East Attacks, Inflation Fears Weigh on Stocks -- WSJ

19 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

19 mrt 2026, 20:19 UTC

Belangrijke Nieuwsgebeurtenissen

Brent Crude Retreats After Touching $119 -- WSJ

19 mrt 2026, 19:49 UTC

Marktinformatie

Brent Crude Seen Potentially Rising to Top Its 2008 High -- Market Talk

19 mrt 2026, 19:26 UTC

Belangrijke Nieuwsgebeurtenissen

U.S. Consumers Face 'Global Oil Shock.' The Iran War Is Retail's Latest Challenge. -- Barrons.com

19 mrt 2026, 19:10 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Natural Gas Rises in Volatile Trading -- Market Talk

19 mrt 2026, 19:06 UTC

Belangrijke Nieuwsgebeurtenissen

Brent Crude Prices Are Surging. Why Europe Is Facing an Energy Shock and the U.S. Isn't. -- Barrons.com

19 mrt 2026, 18:08 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Silver Extends Slide to Seven Straight Sessions -- Market Talk

Peer Vergelijking

Prijswijziging

Avita Therapeutics Inc Prognose

Koersdoel

By TipRanks

51.07% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6.33 USD 51.07%

Hoogste 10 USD

Laagste 3.5 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avita Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

4 ratings

Buy

Hold

Sell

Gebaseerd op 4 analisten die aandelenratings hebben gegeven aan Avita Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

8.83 / 9.77Steun & Weerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.